Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: A cross-sectional study

被引:39
作者
Xing, Liying [1 ,2 ]
Jing, Li [2 ]
Tian, Yuanmeng [2 ]
Yan, Han [2 ]
Zhang, Boqiang [2 ]
Sun, Qun [3 ]
Dai, Dong [4 ]
Shi, Lei [5 ]
Liu, Da [2 ]
Yang, Zuosen [2 ]
Liu, Shuang [6 ]
机构
[1] China Med Univ, Dept Cardiol, First Hosp, Shenyang, Liaoning, Peoples R China
[2] Liaoning Prov Ctr Dis Control & Prevent, Dept Chron Dis, Shenyang, Liaoning, Peoples R China
[3] Dept Chron Dis Dis Control & Prevent Chao Yang Ci, Chaoyang, Liaoning, Peoples R China
[4] Dept Chron Dis Dis Control & Prevent Dan Dong Cit, Dan Dong, Liaoning, Peoples R China
[5] Dept Chron Dis Dis Control & Prevent Liao Yang Ci, Liaoyang, Liaoning, Peoples R China
[6] China Med Univ, Dept Cardiovasc Ultrasound, First Hosp, Shenyang, Liaoning, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Dyslipidemia; Prevalence; Risk factors; Control; China; PREVALENCE; STROKE; BURDEN; HYPERTENSION; MORTALITY;
D O I
10.1016/j.numecd.2020.07.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Management of dyslipidemia remains the cornerstone for prevention of cardiovascular diseases. We aimed to evaluate the epidemiology of dyslipidemia in northeast China. Methods and results: This cross-sectional survey was administered on 18,796 participants aged >= 40 years from September 2017 to March 2019 through a multistage, stratified, and cluster random sampling method. Lipid profiles were proposed by National Cholesterol Education Program Adult Treatment Panel III. The crude prevalence of dyslipidemia was 35.8%, higher in urban and women than their counterparts (49.5% vs 30.2%, 37.6% vs 33.0%, p < 0.001). The age-standardized prevalence of dyslipidemia was 34.0% (urban 47.9%, and rural 28.9%; men 36.2%, and women 33.4%). The prevalence of high total cholesterol (TC), high triglyceride (TG), high low-density lipoprotein cholesterol (LDL-C) and low high-density lipoprotein cholesterol (HDL-C) were 14.2%, 17.7%, 5.7% and 11.4% respectively. Noticeably, the prevalence of high LDL-C and low HDL-C in urban areas showed a 2.2-fold and 6.3-fold increase over the rural areas (9.3% vs 4.2% and 28.4% vs 4.5%, respectively). Among participants with dyslipidemia, 14.7% were aware of their condition; 5.9% were taking lipid-regulating medications; and only 2.9% had their dyslipidemia controlled. Comorbidities including hypertension (63.6%), and diabetes (25.2%) were highly prevalent in patients with dyslipidemia, however, the control rates of those comorbidities were only 40.0% and 6.6%. Conclusions: Patients with dyslipidemia showed high cardiovascular burden with low control rates of dyslipidemia, high prevalence of coexisting risk factors. Therefore, region- and sex-specific strategies to manage dyslipidemia and related risk factors should be highlighted. (C) 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2262 / 2270
页数:9
相关论文
共 24 条
  • [1] [Anonymous], 2011, WHO I Global atlas on cardiovascular disease prevention and control
  • [2] Census Office of The State Council of China NBoSoC, 2012, TAB 201 POP CENS PEO
  • [3] Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study
    Feigin, Valery L.
    Krishnamurthi, Rita V.
    Parmar, Priya
    Norrving, Bo
    Mensah, George A.
    Bennett, Derrick A.
    Barker-Collo, Suzanne
    Moran, Andrew E.
    Sacco, Ralph L.
    Truelsen, Thomas
    Davis, Stephen
    Pandian, Jeyaraj Durai
    Naghavi, Mohsen
    Forouzanfar, Mohammad H.
    Nguyen, Grant
    Johnson, Catherine O.
    Vos, Theo
    Meretoja, Atte
    Murray, Christopher J. L.
    Roth, Gregory A.
    Abd-Allah, Foad
    Abera, Semaw Ferede
    Akinyemi, Rufus Olusola
    Salman, Rustam Al-Shahi
    Anderson, Craig S.
    Bahit, Maria Cecilia
    Banerjee, Amitava
    Basu, Sanjay
    Beauchamp, Norman J.
    Bornstein, Natan M.
    Brainin, Michael
    Cabral, Norberto Luiz
    Campos-Nonato, Ismael
    Caso, Valeria
    Catala-Lopez, Ferrán
    Chowdhury, Rajiv
    Christensen, Hanne K.
    Connor, Myles D.
    deVeber, Gabrielle
    Dharmaratne, Samath D.
    Dokova, Klara
    Donnan, Geoffrey
    Endres, Matthias
    Fernandes, Jefferson Gomes
    Gankpe, Fortune
    Geleijnse, Johanna M.
    Gillium, Richard F.
    Giroud, Maurice
    Hamadeh, Randah R.
    Hankey, Graeme J.
    [J]. NEUROEPIDEMIOLOGY, 2015, 45 (03) : 161 - 176
  • [4] Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries
    Gaziano, Thomas A.
    Bitton, Asaf
    Anand, Shuchi
    Abrahams-Gessel, Shafika
    Murphy, Adrianna
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2010, 35 (02) : 72 - 115
  • [5] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, R
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Cleeman, JI
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    Keller, SA
    Jehle, AJ
    [J]. CIRCULATION, 2002, 106 (25) : 3143 - 3421
  • [6] Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013
    Guan, Tianjia
    Ma, Jing
    Li, Mei
    Xue, Tao
    Lan, Zongmin
    Guo, Jian
    Shen, Ying
    Chao, Baohua
    Tian, Geyuan
    Zhang, Qiang
    Wang, Longde
    Liu, Yuanli
    [J]. NEUROLOGY, 2017, 89 (01) : 53 - 61
  • [7] Dyslipidemia
    Kopin, Laurie
    Lowenstein, Charles
    [J]. ANNALS OF INTERNAL MEDICINE, 2017, 167 (11) : ITC81 - ITC95
  • [8] The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China
    Lewington, Sarah
    Lacey, Ben
    Clarke, Robert
    Guo, Yu
    Kong, Xiang Ling
    Yang, Ling
    Chen, Yiping
    Bian, Zheng
    Chen, Junshi
    Meng, Jinhuai
    Xiong, Youping
    He, Tianyou
    Pang, Zengchang
    Zhang, Shuo
    Collins, Rory
    Peto, Richard
    Li, Liming
    Chen, Zhengming
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (04) : 524 - 532
  • [9] Prevalence, awareness, treatment and control of dyslipidemia among adults in Northwestern China: the cardiovascular risk survey
    Luo, Jun-yi
    Ma, Yi-Tong
    Yu, Zi-xiang
    Yang, Yi-Ning
    Xie, Xiang
    Ma, Xiang
    Liu, Fen
    Li, Xiao-mei
    Chen, Bang-dang
    [J]. LIPIDS IN HEALTH AND DISEASE, 2014, 13
  • [10] Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]